Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AbiPointe Biotechnology

Out of Business LATEST DEAL TYPE

Developer of an imaging technology for deoxyribonucleic acid research. The company develops an imaging technology that improves the quality of the screening time period and subcloned hybridoma cells in double-stranded deoxyribonucleic acid viruses.

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Primary Office
  • 704 Willivee Drive
  • Decatur, GA 30033
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AbiPointe Biotechnology’s full profile, request a free trial.

AbiPointe Biotechnology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Sep-2018 Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »